Funder: Ionis Pharmaceuticals
Due Dates: May 29, 2026 (Full application deadline)
Funding Amounts: $50,000 per year, up to 2 years (total $100,000 possible); 2 awards annually
Summary: Supports early-career researchers conducting innovative research on Angelman Syndrome to advance diagnosis, understanding, and patient care.
Key Information: Applications must be submitted by email; late or incomplete applications are not considered.